...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Trading
1
Sep 19, 2022 03:22PM
1
Sep 20, 2022 02:03PM
3
Sep 20, 2022 03:01PM

Hmmm, that's interesting. See 2A.  CTO should be lifted once that's corrected I would expect.

https://cto-iov.csa-acvm.ca/ArticleFile.asp?Instance=101&ID=E4A6BCAF076F4977A3E39662B5B6CC47

4
Sep 20, 2022 06:22PM
4
Sep 21, 2022 12:02PM
2
Sep 21, 2022 01:26PM
2
Sep 21, 2022 04:29PM
2
Sep 21, 2022 07:27PM
3
Sep 21, 2022 08:34PM
5
Sep 22, 2022 03:16PM
6
Sep 22, 2022 03:27PM
3
Sep 23, 2022 08:35AM
Share
New Message
Please login to post a reply